Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation - PubMed (original) (raw)

B Bolon, S Kahn, B D Bennett, S Babu-Khan, P Denis, W Fan, H Kha, J Zhang, Y Gong, L Martin, J C Louis, Q Yan, W G Richards, M Citron, R Vassar

Affiliations

• PMID: 11224535
• DOI: 10.1038/85059

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

Y Luo et al. Nat Neurosci. 2001 Mar.

No abstract available

PubMed Disclaimer

Similar articles

• BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.
  Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. Cai H, et al. Nat Neurosci. 2001 Mar;4(3):233-4. doi: 10.1038/85064. Nat Neurosci. 2001. PMID: 11224536 No abstract available.
• Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
  Hartlage-Rübsamen M, Zeitschel U, Apelt J, Gärtner U, Franke H, Stahl T, Günther A, Schliebs R, Penkowa M, Bigl V, Rossner S. Hartlage-Rübsamen M, et al. Glia. 2003 Jan 15;41(2):169-79. doi: 10.1002/glia.10178. Glia. 2003. PMID: 12509807
• beta-Secretase, APP and Abeta in Alzheimer's disease.
  Vassar R. Vassar R. Subcell Biochem. 2005;38:79-103. Subcell Biochem. 2005. PMID: 15709474 Review.
• Beta-secretase as a target for the treatment of Alzheimer's disease.
  Citron M. Citron M. J Neurosci Res. 2002 Nov 1;70(3):373-9. doi: 10.1002/jnr.10393. J Neurosci Res. 2002. PMID: 12391600 Review.
• Alzheimer's disease. Closing in on gamma-secretase.
  De Strooper B. De Strooper B. Nature. 2000 Jun 8;405(6787):627, 629. doi: 10.1038/35015193. Nature. 2000. PMID: 10864307 No abstract available.

Cited by

• Amyloid-β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects.
  Yu Y, Yu S, Battaglia G, Tian X. Yu Y, et al. Ibrain. 2024 May 23;10(3):266-289. doi: 10.1002/ibra.12155. eCollection 2024 Fall. Ibrain. 2024. PMID: 39346788 Free PMC article. Review.
• Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Dementia: A Pilot Study.
  Saraceno C, Cervellati C, Trentini A, Crescenti D, Longobardi A, Geviti A, Bonfiglio NS, Bellini S, Nicsanu R, Fostinelli S, Mola G, Riccetti R, Moretti DV, Zanetti O, Binetti G, Zuliani G, Ghidoni R. Saraceno C, et al. Int J Mol Sci. 2024 Jul 30;25(15):8354. doi: 10.3390/ijms25158354. Int J Mol Sci. 2024. PMID: 39125924 Free PMC article.
• The duality of amyloid-β: its role in normal and Alzheimer's disease states.
  Azargoonjahromi A. Azargoonjahromi A. Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1. Mol Brain. 2024. PMID: 39020435 Free PMC article. Review.
• Myeloid ectopic viral integration site 2 accelerates the progression of Alzheimer's disease.
  Cui Y, Zhang X, Liu J, Hou Y, Song Q, Cao M, Zhang J, Wang X, Liu C, Wang P, Wang Y. Cui Y, et al. Aging Cell. 2024 Oct;23(10):e14260. doi: 10.1111/acel.14260. Epub 2024 Jul 12. Aging Cell. 2024. PMID: 38994634 Free PMC article.
• Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.
  Shukla D, Suryavanshi A, Bharti SK, Asati V, Mahapatra DK. Shukla D, et al. Curr Top Med Chem. 2024;24(19):1699-1737. doi: 10.2174/0115680266299847240328045737. Curr Top Med Chem. 2024. PMID: 38566385 Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)